COLOMA JASON V (Chief Executive Officer) sold 10.7% of their position (34.50K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.03M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/2/2026ACC: 0001676170-26-000014
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-34.50K
Net shares
Net seller
$1.03M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
34.50K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−2.59K
Price / share
$29.98
Trade value
$77.73K
% of position
10.0%
7/1/2026
25.93K→23.34K
Common Stock
Indirect
Shares
−30.31K
Price / share
$29.95
Trade value
$907.92K
% of position
9.5%
7/1/2026
319.08K→288.77K
Common Stock
Indirect
Shares
−1.60K
Price / share
$30.44
Trade value
$48.61K
% of position
0.6%
7/1/2026
288.77K→287.17K
Total
Net shares
−34.50K
Net value
-$1.03M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/1/2026 | S · Sale | −2.59K | $29.98 | $77.73K | 10.0% | 25.93K | 23.34K |
| Common Stock Indirect | 7/1/2026 | S · Sale | −30.31K | $29.95 | $907.92K | 9.5% | 319.08K | 288.77K |
| Common Stock Indirect | 7/1/2026 | S · Sale | −1.60K | $30.44 | $48.61K | 0.6% | 288.77K | 287.17K |
| Total | −34.50K | -$1.03M | ||||||
Derivative Transactions0
No derivative transactions reported